Primiano Christopher Brett

Average Profitability
28.28%
Insider Buys Quantity
1
Insider Buys Sum
$53,500.00
Insider Sells Quantity
23
Insider Sells Sum
$6.16M

Insider Activity of Primiano Christopher Brett

The largest purchase of all time was on 2014-05-13 and amounted to 2000 shares of Karyopharm Therapeutics Inc. for $53,500.

The largest sale of all time was on 2020-12-01 and amounted to 137061 share of Karyopharm Therapeutics Inc. for $2.4M.

Biography of Primiano Christopher Brett

No biography is available at this moment.

2020-12-01SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
137,061
0.1926%
$17.53$2.4M-44.3%
2020-11-02SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
772
0.0011%
$14.92$11,518-30.72%
2020-10-13SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
39,271
0.057%
$16.86$661,969-34.38%
2020-09-08SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
10,054
0.0139%
$14.98$150,609-17.45%
2020-05-07SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
9,660
0.0134%
$19.73$190,627-21.53%
2020-03-02SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
26,500
0.0359%
$25.37$672,279-41.54%
2020-02-19SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
2,961
0.0044%
$16.48$48,803-0.43%
2019-12-27SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
10,000
0.0127%
$15.20$151,950-11.74%
2019-12-06SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
26,000
0.0342%
$13.26$344,676+5.77%
2018-09-10SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
20,000
0.0323%
$18.90$378,092-54.43%
2018-05-10SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
4,000
0.0076%
$18.01$72,048-35.45%
2018-03-05SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
5,000
0.01%
$16.03$80,152-7.48%
2018-02-16SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
2,972
0.006%
$15.01$44,596+1.44%
2018-02-15SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
2,028
0.0042%
$15.02$30,458+2.57%
2018-02-07SaleKaryopharm Therapeutics Inc.
KPTI
EVP, CBO, GC & Secretary
3,000
0.006%
$13.00$39,000+15.56%
2017-12-12SaleKaryopharm Therapeutics Inc.
KPTI
SVP, OPS, BUS DEV, GC & SEC
34,000
0.0722%
$9.92$337,232+57.81%
2017-12-11SaleKaryopharm Therapeutics Inc.
KPTI
SVP, OPS, BUS DEV, GC & SEC
20,084
0.0427%
$10.88$218,512+44.15%
2017-11-07SaleKaryopharm Therapeutics Inc.
KPTI
SVP, OPS, BUS DEV, GC & SEC
9,916
0.0209%
$11.25$111,510+38.14%
2017-10-02SaleKaryopharm Therapeutics Inc.
KPTI
SVP, OPS, BUS DEV, GC & SEC
3,000
0.0062%
$12.00$36,000+24.77%
2017-09-15SaleKaryopharm Therapeutics Inc.
KPTI
SVP, OPS, BUS DEV, GC & SEC
4,000
0.0085%
$11.00$44,000+32.64%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.